Identification and characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents

Cellular and Molecular Life Sciences

Volumn 67, Issue 7, 2010, Pages 1147-1163

  Córdoba Chacón, Jose ^a,b,c   Gahete, Manuel D ^a,b,c   Duran Prado, Mario ^a,b,c   Pozo Salas, Ana I ^a,b,c   Malagón, María M ^a,b,c   Gracia Navarro, F ^a,b,c   Kineman, Rhonda D ^d,e   Luque, Raul M ^a,b,c   Castaño, Justo P ^a,b,c  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d JESSE BROWN VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cortistatin; Metabolism; Mouse models; Somatostatin receptor; Truncated receptor

Indexed keywords

CALCIUM ION; CORTISTATIN; CYCLIC AMP; LIGAND; SOMATOSTATIN; SOMATOSTATIN RECEPTOR 5; CALCIUM; ISOPROTEIN; SOMATOSTATIN RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROTEIN DOMAIN; PROTEIN VARIANT; RAT; RODENT; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; ANIMAL; C57BL MOUSE; CELL LINE; CHO CELL; CRICETULUS; FEMALE; GENETICS; HAMSTER; HYPOPHYSIS TUMOR; HYPOTHALAMUS; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; WISTAR RAT;

MUS; RATTUS; RODENTIA;

ANIMALS; BASE SEQUENCE; CALCIUM; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; FEMALE; HYPOTHALAMUS; LIGANDS; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PITUITARY NEOPLASMS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, WISTAR; RECEPTORS, SOMATOSTATIN;

EID: 77950605987     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-009-0240-y     Document Type: Article

References (77)

1. Gahete MD, Duran-Prado M, Luque RM, Martinez-Fuentes AJ, Vazquez-Martinez R, Malagon MM, Castaño JP (2008) Are somatostatin and cortistatin two siblings in regulating endocrine secretions? In vitro work ahead. Mol Cell Endocrinol 286:128-134
2. Luque RM, Park S, Kineman RD (2008) Role of endogenous somatostatin in regulating GH output under basal conditions and in response to metabolic extremes. Mol Cell Endocrinol 286:155-168
3. Moller LN, Stidsen CE, Hartmann B, Holst JJ (2003) Somatostatin receptors. Biochim Biophys Acta 1616:1-84
4. Patel YC (1999) Somatostatin and its receptor family. Front Neuroendocrinol 20:157-198
5. Viollet C, Lepousez G, Loudes C, Videau C, Simon A, Epelbaum J (2008) Somatostatinergic systems in brain: networks and functions. Mol Cell Endocrinol 286:75-87 (Pubitemid 351680238)
6. Broglio F, Grottoli S, Arvat E, Ghigo E (2008) Endocrine actions of cortistatin: in vivo studies. Mol Cell Endocrinol 286:123-127
7. de Lecea L (2008) Cortistatin: functions in the central nervous system. Mol Cell Endocrinol 286:88-95
8. de Lecea L, Castaño JP (2006) Cortistatin: not just another somatostatin analog. Nat Clin Pract Endocrinol Metab 2:356-357 (Pubitemid 44050101)
9. de Lecea L, Criado JR, Prospero-Garcia O, Gautvik KM, Schweitzer P, Danielson PE, Dunlop CL, Siggins GR, Henriksen SJ, Sutcliffe JG (1996) A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381:242-245 (Pubitemid 26148671)
10. Gonzalez-Rey E, Delgado M (2008) Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders. Mol Cell Endocrinol 286:135-140 (Pubitemid 351680232)
11. CastañoJP,Delgado-NieblaE,Duran-PradoM,LuqueRM,Sanchez-HormigoA, Gracia-NavarroF,Garcia-NavarroS,KinemanRD,MalagonMM(2005) NewinsightsinthemechanismbywhichSRIFinfluencesGHsecretion.JEndocrinolInvest28: 10-13(Pubitemid46211833)
12. PatelYC,PanettaR,EscherE,GreenwoodM,SrikantCB(1994) ExpressionofmultiplesomatostatinreceptorgenesinAtT-20cells: evidenceforanovelsomatostatin-28selectivereceptorsubtype.JBiolChem269: 1506-1509(Pubitemid24032550)
13. Siehler S, Nunn C, Hannon J, Feuerbach D, Hoyer D (2008) Pharmacological profile of somatostatin and cortistatin receptors. Mol Cell Endocrinol 286:26-34
14. 2+ current in the pituitary cell line AtT-20. Neuroscience 71:1073-1081
15. DeghenghiR,PapottiM,GhigoE,MuccioliG(2001)Cortistatin,butnotsomatostatin, binds-growthhormonesecretagogue(GHS)receptorsofhumanpituitarygland. JEndocrinolInvest24:RC1-RC3(Pubitemid32166321)
16. Robas N, Mead E, Fidock M (2003) MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion. J Biol Chem 278:44400-44404 (Pubitemid 37377189)
17. Liu Y, Zhou YB, Zhang GG, Cai Y, Duan XH, Teng X, Song JQ, Shi Y, Tang CS, Yin XH, Qi YF (2010). Cortistatin attenuates vascular calcification in rats. Regul Pept 159: 35-43 (doi:10.1016/j.regpcp.2009.09.005)
18. Bockaert J, Marin P, Dumuis A, Fagni L (2003) The 'magic tail' of G protein-coupled receptors: an anchorage for functional protein networks. FEBS Lett 546:65-72
19. Bockaert J, Roussignol G, Becamel C, Gavarini S, Joubert L, Dumuis A, Fagni L, Marin P (2004) GPCR-interacting proteins (GIPs): nature and functions. Biochem Soc Trans 32:851-855 (Pubitemid 39524396)
20. Havt A, Schally AV, Halmos G, Varga JL, Toller GL, Horvath JE, Szepeshazi K, Koster F, Kovitz K, Groot K, Zarandi M, Kanashiro CA (2005) The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues. Proc Natl Acad Sci USA 102:17424-17429 (Pubitemid 41740882)
21. Neill JD, Musgrove LC, Duck LW (2004) Newly recognized GnRH receptors: function and relative role. Trends Endocrinol Metab 15:383-392
22. Rekasi Z, Czompoly T, Schally AV, Halmos G (2000) Isolation and sequencing of cDNAs for splice variants of growth hormonereleasing hormone receptors from human cancers. Proc Natl Acad Sci USA 97:10561-10566
23. Chen AM, Perrin MH, Digruccio MR, Vaughan JM, Brar BK, Arias CM, Lewis KA, Rivier JE, Sawchenko PE, Vale WW (2005) A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proc Natl Acad Sci USA 102:2620-2625
24. Hasegawa H, Negishi M, Ichikawa A (1996) Two isoforms of the prostaglandin E receptor EP3 subtype different in agonist-independent constitutive activity. J Biol Chem 271:1857-1860 (Pubitemid 26047763)
25. Miyata I, Shiota C, Ikeda Y, Oshida Y, Chaki S, Okuyama S, Inagami T (1999) Cloning and characterization of a short variant of the corticotropin-releasing factor receptor subtype from rat amygdala. Biochem Biophys Res Commun 256:692-696 (Pubitemid 29301169)
26. Duran-Prado M, Gahete MD, Martinez-Fuentes AJ, Luque RM, Quintero A, Webb SM, Benito-Lopez P, Leal A, Schulz S, Gracia-Navarro F, Malagon MM, Castaño JP (2009) Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors. J Clin Endocrinol Metab 94:2634-2643
27. Zeyda T, Diehl N, Paylor R, Brennan MB, Hochgeschwender U (2001) Impairment in motor learning of somatostatin null mutant mice. Brain Res 906:107-114 (Pubitemid 32595544)
28. Hammer RE, Brinster RL, Rosenfeld MG, Evans RM, Mayo KE (1985) Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth. Nature 315:413-416
29. Luque RM, Park S, Kineman RD (2007) Severity of the catabolic condition differentially modulates hypothalamic expression of growth hormone-releasing hormone in the fasted mouse: potential role of neuropeptide Y and corticotropin-releasing hormone. Endocrinology 148:300-309 (Pubitemid 46021462)
30. Luque RM, Huang ZH, Shah B, Mazzone T, Kineman RD (2007) Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice. Am J Physiol Endocrinol Metab 292:E891-E899
31. Luque RM, Kineman RD (2006) Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function. Endocrinology 147:2754-2763
32. Luque RM, Gahete MD, Hochgeschwender U, Kineman RD (2006) Evidence that endogenous SST inhibits ACTH and ghrelin expression by independent pathways. Am J Physiol Endocrinol Metab 291:E395-E403 (Pubitemid 44035300)
33. Luque RM, Kineman RD (2007) Gender-dependent role of endogenous somatostatin in regulating growth hormone-axis function in mice. Endocrinology 148:5998-6006
34. Luque RM, Soares BS, Peng XD, Krishnan S, Cordoba-Chacon J, Frohman LA, Kineman RD (2009) Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRHreceptor hyperactivation. Endocrinology 150:3177-3185
35. Martinez-Fuentes AJ, Moreno-Fernandez J, Vazquez-Martinez R, Duran-Prado M, de la Riva A, Tena-Sempere M, Dieguez C, Jimenez-Reina L, Webb SM, Pumar A, Leal-Cerro A, BenitoLopez P, Malagon MM, Castaño JP (2006) Ghrelin is produced by and directly activates corticotrope cells from adrenocorticotropinsecreting adenomas. J Clin Endocrinol Metab 91:2225-2231 (Pubitemid 43855010)
36. Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365-386
37. Duran-Prado M, Bucharles C, Gonzalez BJ, Vazquez-Martinez R, Martinez-Fuentes AJ, Garcia-Navarro S, Rhodes SJ, Vaudry H, Malagon MM, Castaño JP (2007) Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization. Endocrinology 148:411-421 (Pubitemid 46021473)
38. Belsham DD, Cai F, Cui H, Smukler SR, Salapatek AM, Shkreta L (2004) Generation of a phenotypic array of hypothalamic neuronal cell models to study complex neuroendocrine disorders. Endocrinology 145:393-400 (Pubitemid 38094535)
39. Kineman RD, Gahete MD, Luque RM (2007) Identification of a mouse ghrelin gene transcript that contains intron 2 and is regulated in the pituitary and hypothalamus in response to metabolic stress. J Mol Endocrinol 38:511-521
40. Luque RM, Kineman RD, Tena-Sempere M (2007) Regulation of hypothalamic expression of KiSS-1 and GPR54 genes by metabolic factors: analyses using mouse models and a cell line. Endocrinology 148:4601-4611
41. Dalm VA, Hofland LJ, Lamberts SW (2008) Future clinical prospects in somatostatin/cortistatin/somatostatin receptor field. Mol Cell Endocrinol 286:262-277
42. Hofland LJ (2008) Somatostatin and somatostatin receptors in Cushing's disease. Mol Cell Endocrinol 286:199-205
43. Lania A, Mantovani G, Spada A (2008) Genetic abnormalities of somatostatin receptors in pituitary tumors. Mol Cell Endocrinol 286:180-186 (Pubitemid 351680235)
44. Schonbrunn A (2008) Selective agonism in somatostatin receptor signaling and regulation. Mol Cell Endocrinol 286:35-39 (Pubitemid 351680239)
45. Siehler S (2008) Cell-based assays in GPCR drug discovery. Biotechnol J 3:471-483 (Pubitemid 351618733)
46. Kilpatrick GJ, Dautzenberg FM, Martin GR, Eglen RM (1999) 7TM receptors: the splicing on the cake. Trends Pharmacol Sci 20:294-301
47. Leung PK, Chow KB, Lau PN, Chu KM, Chan CB, Cheng C H, Wise H (2007) The truncated ghrelin receptor polypeptide (GHSRIb) acts as a dominant-negative mutant of the ghrelin receptor. Cell Signal 19:1011-1022
48. Hawrylyshyn KA, Michelotti GA, Coge F, Guenin SP, Schwinn DA (2004) Update on human alphal-adrenoceptor subtype signaling and genomic organization. Trends Pharmacol Sci 25:449-455 (Pubitemid 39149699)
49. McWilliamsDF,WatsonSA,CrosbeeDM,MichaeliD,SethR(1998) Coexpressionofgastrinandgastrinreceptors(CCK-BanddeltaCCK-B) ingastrointestinaltumourcelllines.Gut42:795-798(Pubitemid28277219)
50. Rogers J, Wall R (1980) A mechanism for RNA splicing. Proc Natl Acad Sci USA 77:1877-1879
51. Tallent M, Dichter MA, Reisine T (1996) Evidence that a novel somatostatin receptor couples to an inward rectifier potassium current in AtT-20 cells. Neuroscience 73:855-864 (Pubitemid 26260946)
52. Burset M, Seledtsov IA, Solovyev VV (2000) Analysis of canonical and non-canonical splice sites in mammalian genomes. Nucleic Acids Res 28:4364-4375
53. Murray JI, Voelker RB, Henscheid KL, Warf MB, Berglund JA (2008) Identification of motifs that function in the splicing of non-canonical introns. Genome Biol 9:R97
54. Black DL (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72:291-336 (Pubitemid 36930448)
55. Smith DJ, Query CC, Konarska MM (2008) "Nought may endure but mutability": spliceosome dynamics and the regulation of splicing. Mol Cell 30:657-666
56. ClarkF,ThanarajTA(2002)Categorizationandcharacterizationoftranscript- confirmedconstitutivelyandalternativelysplicedintronsandexonsfromhuman. HumMolGenet11:451-464(Pubitemid34213619)
57. Fehlmann D, Langenegger D, Schuepbach E, Siehler S, Feuerbach D, Hoyer D (2000) Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery. J Physiol Paris 94:265-281
58. Reubi JC, Waser B, Liu Q, Laissue JA, Schonbrunn A (2000) Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems: membranous versus intracellular location. J Clin Endocrinol Metab 85:3882-3891
59. Stroh T, Sarret P, Tannenbaum GS, Beaudet A (2006) Immunohistochemical distribution and subcellular localization of the somatostatin receptor subtype 1 (sst1) in the rat hypothalamus. Neurochem Res 31:247-257
60. Hukovic N, Panetta R, Kumar U, Rocheville M, Patel YC (1998) The cytoplasmic tail of the human somatostatin receptor type 5 is crucial for interaction with adenylyl cyclase and in mediating desensitization and internalization. J Biol Chem 273:21416-21422 (Pubitemid 28385438)
61. Jacobs S, Schulz S (2008) Intracellular trafficking of somatostatin receptors. Mol Cell Endocrinol 286:58-62
62. Tulipano G, Schulz S (2007) Novel insights in somatostatin receptor physiology. Eur J Endocrinol 156(Suppl 1):S3-S11
63. ClaeysenS,SebbenM,BecamelC,BockaertJ,DumuisA(1999)Novelbrain-specific5- HT4receptorsplicevariantsshowmarkedconstitutiveactivity:roleoftheC- terminalintracellulardomain.MolPharmacol55:910-920(Pubitemid29214611)
64. 2+ stores and ion channels in neurons. Trends Neurosci 23:80-88
65. Namba T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, Kakizuka A, Ito S, Ichikawa A, Narumiya S (1993) Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 365:166-170 (Pubitemid 23282063)
66. Wente W, Stroh T, Beaudet A, Richter D, Kreienkamp HJ (2005) Interactions with PDZ domain proteins PIST/GOPC and PDZK1 regulate intracellular sorting of the somatostatin receptor subtype 5. J Biol Chem 280:32419-32425
67. Peverelli E, Lania AG, Mantovani G, Beck-Peccoz P, Spada A (2009) Characterization of intracellular signaling mediated by human somatostatin receptor 5: role of the DRY motif and the third intracellular loop. Endocrinology 150:3169-3176
68. 2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells. FEBS Lett 348:192-196
69. Ben-Shlomo A, Wawrowsky KA, Proekt I, Wolkenfeld NM, Ren SG, Taylor J, Culler MD, Melmed S (2005) Somatostatin receptor type 5 modulates somatostatin receptor type 2 regulation of adrenocorticotropin secretion. J Biol Chem 280:24011-24021
70. Carruthers AM, Warner AJ, Michel AD, Feniuk W, Humphrey PP (1999) Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins. Br J Pharmacol 126:1221-1229
71. Cervia D, Zizzari P, Pavan B, Schuepbach E, Langenegger D, Hoyer D, Biondi C, Epelbaum J, Bagnoli P (2003) Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1-sst5 receptor-selective nonpeptidyl agonists. Neuropharmacology 44:672-685
72. Park S, Sohn S, Kineman RD (2004) Fasting-induced changes in the hypothalamic-pituitary-GH axis in the absence of GH expression: lessons from the spontaneous dwarf rat. J Endocrinol 180:369-378
73. Ishikawa M, Mizobuchi M, Takahashi H, Bando H, Saito S (1997) Somatostatin release as measured by in vivo microdialysis: circadian variation and effect of prolonged food deprivation. Brain Res 749:226-231
74. TannenbaumGS,EpelbaumJ,ColleE,BrazeauP,MartinJB(1978)Antiserum- somatostatinreversesstarvation- inducedinhibitionofgrowthhormonebutnotinsulinsecretion.Endocrinology102: 1909-1914(Pubitemid8376454)
75. Zhou X, De Schepper J, Vergeylen A, Luis O, Delhase M, Hooghe-Peters EL (1997) Cafeteria diet-induced obese rats have an increased somatostatin protein content and gene expression in the periventricular nucleus. J Endocrinol Invest 20:264-269
76. Luque RM, Park S, Peng XD, Delgado E, Gracia-Navarro F, Kineman RD, Malagon MM, Castaño JP (2004) Homologous and heterologous in vitro regulation of pig pituitary somatostatin receptor subtypes, sstl, sst2 and sst5 mRNA. J Mol Endocrinol 32:437-448
77. Ramirez JL, Mouchantaf R, Kumar U, Otero Corchon V, Rubinstein M, Low MJ, Patel YC (2002) Brain somatostatin receptors are up-regulated in somatostatin-deficient mice. Mol Endocrinol 16:1951-1963